Interdisciplinary Approach for the Medical Management of Gestational Gigantomastia

Abstract

Background Gestational gigantomastia is a rare and debilitating condition that is thought to result from hormone hypersensitivity. Several definitions have been proposed using breast weight and change in body mass index, but the breast growth is best summarized as rapid, diffuse, and excessive.

Case We report a case of a 31-year-old woman with a history of infertility and cystic fibrosis that developed pathologic breast growth during hormonal preparation for in vitro fertilization. Her serum laboratories were unremarkable, and she was medically managed until 31 weeks of gestation. After delivery, she experienced rapid decrease in breast size and was followed by plastic surgery with plan to allow spontaneous regression with interval breast reduction

Conclusion We highlight a successful interdisciplinary medical management approach, which helped to avoid a morbid, intrapartum breast reduction.

Keywords

gigantomastia - pregnancy - cystic fibrosis - infertility - medical management - interdisciplinary

Publication History

Received: 14 April 2020

Accepted: 08 May 2020

Article published online:
23 September 2020

• References

• 1 Rezai S, Nakagawa JT, Tedesco J. et al. Gestational gigantomastia complicating pregnancy: a case report and review of the literature. Case Rep Obstet Gynecol 2015; 2015: 892369
• 2 Mangla M, Singla D. Gestational gigantomastia: a systematic review of case reports. J Midlife Health 2017; 8 (01) 40-44
• 3 Swelstad MR, Swelstad BB, Rao VK, Gutowski KA. Management of gestational gigantomastia. Plast Reconstr Surg 2006; 118 (04) 840-848
• 4 Hedberg K, Karlsson K, Lindstedt G. Gigantomastia during pregnancy: effect of a dopamine agonist. Am J Obstet Gynecol 1979; 133 (08) 928-931